DK2773748T3 - Midthjerne-dopamin (da) neuroner til transplantation - Google Patents
Midthjerne-dopamin (da) neuroner til transplantation Download PDFInfo
- Publication number
- DK2773748T3 DK2773748T3 DK12846715.6T DK12846715T DK2773748T3 DK 2773748 T3 DK2773748 T3 DK 2773748T3 DK 12846715 T DK12846715 T DK 12846715T DK 2773748 T3 DK2773748 T3 DK 2773748T3
- Authority
- DK
- Denmark
- Prior art keywords
- neurones
- transplantation
- brain dopamine
- middle brain
- dopamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Toxicology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161555828P | 2011-11-04 | 2011-11-04 | |
PCT/US2012/063339 WO2013067362A1 (en) | 2011-11-04 | 2012-11-02 | Midbrain dopamine (da) neurons for engraftment |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2773748T3 true DK2773748T3 (da) | 2020-03-16 |
Family
ID=48192829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12846715.6T DK2773748T3 (da) | 2011-11-04 | 2012-11-02 | Midthjerne-dopamin (da) neuroner til transplantation |
Country Status (16)
Country | Link |
---|---|
US (3) | US10280398B2 (da) |
EP (2) | EP2773748B1 (da) |
JP (6) | JP6461602B2 (da) |
KR (4) | KR102581669B1 (da) |
CN (5) | CN113528442A (da) |
AU (3) | AU2012332269B2 (da) |
BR (2) | BR122020000182B8 (da) |
CA (2) | CA2854578C (da) |
DK (1) | DK2773748T3 (da) |
EA (1) | EA201490796A1 (da) |
ES (1) | ES2779453T3 (da) |
HK (1) | HK1201879A1 (da) |
IL (4) | IL286793B (da) |
PL (1) | PL2773748T3 (da) |
PT (1) | PT2773748T (da) |
WO (1) | WO2013067362A1 (da) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8642334B2 (en) | 2009-02-17 | 2014-02-04 | Memorial Sloan Kettering Cancer Center | Methods of neural conversion of human embryonic stem cells |
DK2694644T3 (da) | 2011-03-30 | 2018-04-16 | Cellular Dynamics Int Inc | Priming af pluripotente stamceller til neural differentiering |
US10280398B2 (en) | 2011-11-04 | 2019-05-07 | Memorial Sloan-Kettering Cancer Center | Midbrain dopamine (DA) neurons for engraftment |
AU2014256876B2 (en) | 2013-04-26 | 2020-11-12 | Cornell, University | Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells |
CN105658788B (zh) | 2013-08-06 | 2020-07-10 | 武田药品工业株式会社 | 多巴胺能神经元的制备方法 |
US11767507B2 (en) | 2013-11-08 | 2023-09-26 | The Mclean Hospital Corporation | Methods for efficient generation of GABAergic interneurons from pluripotent stem cells |
US9694036B2 (en) | 2014-03-21 | 2017-07-04 | Cellular Dynamics International, Inc. | Production of midbrain dopaminergic neurons and methods for the use thereof |
WO2015143622A1 (zh) * | 2014-03-25 | 2015-10-01 | 云南中科灵长类生物医学重点实验室 | 一种建立神经上皮干细胞的培养基、方法及其应用 |
JP6761409B2 (ja) | 2014-08-19 | 2020-09-23 | フジフィルム セルラー ダイナミクス,インコーポレイテッド | 多能性幹細胞由来細胞から形成された神経回路網 |
CN107208045B (zh) * | 2014-11-25 | 2018-11-02 | 宾州研究基金会 | 人神经胶质细胞转化成用于大脑和脊髓修复的神经细胞的化学重编程 |
EP3061809B1 (en) | 2015-02-27 | 2019-01-30 | Miltenyi Biotec GmbH | Method for generation of a cell composition of mesencephalic dopaminergic progenitor cells |
EP3281151B1 (en) | 2015-04-10 | 2023-03-29 | President and Fellows of Harvard College | Methods and devices for live cell imaging analysis |
US10081791B2 (en) | 2015-05-07 | 2018-09-25 | William J. Freed | Modeling connections between dopaminergic neurons and the cerebral cortex |
ES2910032T3 (es) * | 2015-06-01 | 2022-05-11 | Memorial Sloan Kettering Cancer Center | Métodos de diferenciación in vitro de neuronas dopaminérgicas del mesencéfalo (mDA) |
JP7023840B2 (ja) | 2015-10-07 | 2022-02-22 | メモリアル スローン ケタリング キャンサー センター | 神経筋接合活性のモジュレーターを同定するin vitroの方法 |
CN105567642B (zh) * | 2016-02-01 | 2019-07-12 | 中国科学院生物物理研究所 | 一种着色性干皮病人多能干细胞的制备方法 |
CA3013623A1 (en) * | 2016-02-05 | 2017-08-10 | Memorial Sloan-Ketering Cancer Center | Methods of differentiating stem cell-derived ectodermal lineage precursors |
WO2017176779A1 (en) * | 2016-04-05 | 2017-10-12 | The Regents Of The University Of California | Cellularized hydrogels and methods of using the same |
CN105861532A (zh) * | 2016-04-08 | 2016-08-17 | 北京大学深圳医院 | 一种基于miRNA491调节DAT基因表达的方法 |
KR101870240B1 (ko) * | 2016-04-12 | 2018-06-22 | 서울대학교산학협력단 | 지방줄기세포에서 신경줄기세포, 신경세포 및 가바성 신경세포로의 분화 유도 방법 |
WO2017183736A1 (ja) * | 2016-04-22 | 2017-10-26 | 国立大学法人京都大学 | ドーパミン産生神経前駆細胞の製造方法 |
EP4328301A3 (en) * | 2016-08-16 | 2024-06-19 | FUJIFILM Cellular Dynamics, Inc. | Methods for differentiating pluripotent cells |
FR3058892B1 (fr) * | 2016-11-23 | 2021-04-09 | Univ Bordeaux | Unite de tissu neural et utilisation d'une telle unite pour l'implantation dans le systeme nerveux d'un mammifere |
CA3057104A1 (en) * | 2017-03-21 | 2018-09-27 | Memorial Sloan-Kettering Cancer Center | Stem cell-derived astrocytes, methods of making and methods of use |
CA3064864A1 (en) * | 2017-05-25 | 2018-11-29 | New York Stem Cell Foundation, Inc. | Method and composition for generating basal forebrain cholinergic neurons (bfcns) |
CN107828728A (zh) * | 2017-10-26 | 2018-03-23 | 中山大学 | 一种制备中脑多巴胺神经元的方法 |
KR102201417B1 (ko) * | 2018-05-02 | 2021-01-11 | (주) 에스바이오메딕스 | 도파민 신경세포의 분리방법 및 이를 이용하여 분리된 도파민 신경세포를 포함하는 파킨슨병 치료용 약제학적 조성물 |
KR102111030B1 (ko) * | 2018-05-10 | 2020-05-14 | 한국과학기술원 | Jab1을 포함하는 신경세포 분화 탐지용 바이오마커 또는 신경세포 분화 촉진용 조성물 |
CN113728103A (zh) * | 2018-12-11 | 2021-11-30 | 罗切斯特大学 | 治疗精神分裂症和其他神经精神病症的方法 |
CN112011510B (zh) * | 2019-05-30 | 2023-01-03 | 中国科学院上海有机化学研究所 | 一种由人多能干细胞制备多巴胺神经元的方法 |
CA3145700A1 (en) | 2019-07-25 | 2021-01-28 | Jeanne F. Loring | Methods of identifying dopaminergic neurons and progenitor cells |
KR102183208B1 (ko) * | 2019-07-25 | 2020-11-25 | 한국과학기술연구원 | Ngn2(neurogenin-2)를 이용하여 척수 손상 모델에서 반응성 성상세포를 신경세포로 리프로그래밍하는 방법 |
CN114729323A (zh) * | 2019-11-22 | 2022-07-08 | 诺和诺德股份有限公司 | 旋转聚集的神经微球及其应用 |
TW202202155A (zh) | 2020-03-25 | 2022-01-16 | 美商薩那生物科技公司 | 用於治療神經病症及病況之低免疫原性神經細胞 |
KR20220164012A (ko) * | 2020-04-02 | 2022-12-12 | 메모리얼 슬로안 케터링 캔서 센터 | 중간뇌 도파민 뉴런의 생성 방법, 중간뇌 뉴런 및 이의 용도 |
WO2021216623A1 (en) | 2020-04-21 | 2021-10-28 | Aspen Neuroscience, Inc. | Gene editing of lrrk2 in stem cells and method of use of cells differentiated therefrom |
WO2021216622A1 (en) | 2020-04-21 | 2021-10-28 | Aspen Neuroscience, Inc. | Gene editing of gba1 in stem cells and method of use of cells differentiated therefrom |
CN114292814A (zh) * | 2020-09-22 | 2022-04-08 | 上海跃赛生物科技有限公司 | 一种多能干细胞分化为中脑黒质多巴胺能神经细胞的方法 |
US20240219375A1 (en) | 2021-04-07 | 2024-07-04 | FUJIFILM Cellular Dynamics, Inc. | Dopaminergic precursor cells and methods of use |
US20220333071A1 (en) | 2021-04-16 | 2022-10-20 | Brainxell, Inc. | Methods of making, expanding and purifying midbrain dopaminergic progenitor cells |
US20240207324A1 (en) * | 2021-04-21 | 2024-06-27 | Shanghai Unixell Biotechnology Co., Ltd. | Method for quality control and enrichment of human dopaminergic neural precursor cells |
CN113388580B (zh) * | 2021-06-16 | 2022-02-18 | 中国医学科学院医学实验动物研究所 | 一种诱导脂肪干细胞分化为功能性多巴胺能神经元的方法及用途 |
WO2022266527A1 (en) * | 2021-06-18 | 2022-12-22 | Memorial Sloan-Kettering Cancer Center | Methods of generating sacral neural crest lineages and uses thereof |
CA3222505A1 (en) * | 2021-07-14 | 2023-01-19 | Sang Hun Lee | Composition for inhibiting alpha-synuclein aggregation and method for inhibiting alpha-synuclein aggregation |
WO2023004370A1 (en) | 2021-07-21 | 2023-01-26 | Aspen Neuroscience, Inc. | Aav-based modulation of gba1 and related compositions and uses thereof |
WO2023004371A1 (en) * | 2021-07-21 | 2023-01-26 | Aspen Neuroscience, Inc. | Methods of differentiating neural cells and predicting engraftment thereof and related compositions |
WO2023004366A1 (en) | 2021-07-21 | 2023-01-26 | Aspen Neuroscience, Inc. | Transposon-based modulation of gba1 and related compositions and uses thereof |
CN113481160B (zh) * | 2021-08-20 | 2022-04-29 | 北京太东生物科技有限公司 | 视网膜色素上皮细胞诱导培养基及其应用 |
KR20240055838A (ko) | 2021-09-10 | 2024-04-29 | 후지필름 셀룰러 다이내믹스, 인코포레이티드 | 유도된 만능 줄기 세포 유래된 세포의 조성물 및 이의 사용 방법 |
CN117089520A (zh) * | 2021-10-28 | 2023-11-21 | 中国科学院动物研究所 | 一种中脑多巴胺细胞群、其制造方法以及用途 |
KR20240099369A (ko) | 2021-10-29 | 2024-06-28 | 후지필름 셀룰러 다이내믹스, 인코포레이티드 | 돌연변이를 포함하는 도파민성 뉴런 및 이의 사용 방법 |
WO2023104792A1 (en) | 2021-12-07 | 2023-06-15 | Vib Vzw | Enhancers of neuronal maturation |
WO2023177919A1 (en) * | 2022-03-18 | 2023-09-21 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for improving in vivo survival of midbrain dopamine neurons |
WO2023201361A1 (en) | 2022-04-15 | 2023-10-19 | Aspen Neuroscience, Inc. | Methods of classifying the differentiation state of cells and related compositions of differentiated cells |
CN115521903B (zh) * | 2022-09-30 | 2024-05-17 | 中国科学院生态环境研究中心 | 体外诱导人多能干细胞分化为多巴胺能神经元的方法 |
Family Cites Families (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2740320B2 (ja) | 1988-08-04 | 1998-04-15 | アムラド・コーポレイション・リミテッド | 胚幹細胞のインビトロ増殖 |
US5340740A (en) | 1992-05-15 | 1994-08-23 | North Carolina State University | Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process |
US5589376A (en) | 1992-07-27 | 1996-12-31 | California Institute Of Technology | Mammalian neural crest stem cells |
US5453357A (en) | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
US5523226A (en) | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
US6787356B1 (en) | 1998-07-24 | 2004-09-07 | The United States Of America As Represented By The Department Of Health And Human Services | Cell expansion system for use in neural transplantation |
US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
US6610540B1 (en) | 1998-11-18 | 2003-08-26 | California Institute Of Technology | Low oxygen culturing of central nervous system progenitor cells |
US20050042749A1 (en) | 2001-05-16 | 2005-02-24 | Carpenter Melissa K. | Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease |
US7005252B1 (en) | 2000-03-09 | 2006-02-28 | Wisconsin Alumni Research Foundation | Serum free cultivation of primate embryonic stem cells |
US7011828B2 (en) | 2000-03-14 | 2006-03-14 | Es Cell International Pte. Ltd. | Implanting neural progenitor cells derived for human embryonic stem cells |
WO2001068815A1 (en) | 2000-03-14 | 2001-09-20 | Es Cell International Pte Ltd | Embryonic stem cells and neural progenitor cells derived therefrom |
KR100903755B1 (ko) | 2000-05-17 | 2009-06-18 | 제론 코포레이션 | 신경 선조세포 집단 |
US7250294B2 (en) * | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
JP4795616B2 (ja) | 2000-06-20 | 2011-10-19 | イーエス・セル・インターナショナル・プライヴェート・リミテッド | Bmp−2経路アンタゴニストの存在下においてes細胞を培養することによって胚性幹細胞の分化をコントロールする方法 |
DE10037759A1 (de) | 2000-08-03 | 2002-07-04 | Gruenenthal Gmbh | Screeningverfahren |
CA2424062A1 (en) | 2000-09-29 | 2002-04-04 | Derek Van Der Kooy | Primitive neural stem cells and method for differentiation of stem cells to neural cells |
JP3660601B2 (ja) | 2001-03-30 | 2005-06-15 | 独立行政法人科学技術振興機構 | 胚性幹細胞からの神経幹細胞、運動ニューロン及びgaba作動性ニューロンの製造法 |
US20030036195A1 (en) | 2001-04-20 | 2003-02-20 | Lorenz Studer | Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use |
US20030211605A1 (en) | 2001-05-01 | 2003-11-13 | Lee Sang-Hun | Derivation of midbrain dopaminergic neurons from embryonic stem cells |
US6887706B2 (en) | 2001-10-03 | 2005-05-03 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of transplantable neural precursor cells from primate embryonic stem cells |
US20040224302A1 (en) | 2002-07-16 | 2004-11-11 | Thomas Jessel | Systems and methods for screening for modulators of neural differentiation |
EP1546198A1 (en) | 2002-07-31 | 2005-06-29 | Stem Cell Therapeutics Inc. | Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap) |
AU2003276924A1 (en) | 2002-09-25 | 2004-04-19 | Bresagen, Inc. | Compositions and methods for enrichment of neural stem cells using ceramide analogs |
AU2003296316A1 (en) | 2002-12-09 | 2004-06-30 | The Mclean Hospital Corporation | Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases |
US7252995B2 (en) | 2002-12-13 | 2007-08-07 | Yu-Show Fu | Method of generating neurons from stem cells and medium for culturing stem cells |
ZA200401646B (en) * | 2003-03-12 | 2004-06-07 | Reliance Life Sciences Pvt Ltd | Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells. |
WO2004091663A1 (ja) | 2003-04-18 | 2004-10-28 | Kyowa Hakko Kogyo Co., Ltd. | 神経再生薬 |
CA2457296A1 (en) | 2003-08-19 | 2005-02-19 | Takahiro Ochiya | Methods for inducing differentiation of pluripotent cells |
WO2006042105A2 (en) | 2004-10-05 | 2006-04-20 | Memorial Sloan Kettering Cancer Center | Promotion of cell migration and axon regeneration in the cns |
WO2007058982A2 (en) * | 2005-11-10 | 2007-05-24 | Genervon Biopharmaceuticals Llc | Mntf differentiation and growth of stem cells |
TW200815597A (en) | 2006-03-30 | 2008-04-01 | Univ Edinburgh | Culture medium containing kinase inhibitors, and uses thereof |
WO2008018190A1 (fr) | 2006-08-09 | 2008-02-14 | Biomaster, Inc. | Cellules de la crête neurale dérivées de tissu adipeux |
JP2008099662A (ja) | 2006-09-22 | 2008-05-01 | Institute Of Physical & Chemical Research | 幹細胞の培養方法 |
GB0622394D0 (en) | 2006-11-09 | 2006-12-20 | Univ Cambridge Tech | Differentiation of pluripotent cells |
EP2446903B1 (en) | 2006-11-20 | 2019-10-09 | President and Fellows of Harvard College | Compositions for treating itch |
US7892830B2 (en) | 2007-01-17 | 2011-02-22 | Wisconsin Alumni Research Foundation | Clonal culture of human pluripotent stem cells |
KR20130030309A (ko) | 2008-02-06 | 2013-03-26 | 가부시키가이샤 구라레 | 세포 배양 방법 및 스크리닝 방법 |
CN101550406B (zh) | 2008-04-03 | 2016-02-10 | 北京大学 | 制备多潜能干细胞的方法,试剂盒及用途 |
WO2009155301A2 (en) | 2008-06-17 | 2009-12-23 | The Mclean Hospital Corporation | Multipotent neural cells |
WO2010042669A2 (en) * | 2008-10-07 | 2010-04-15 | Ipierian, Inc. | Co-culture compositions and methods |
EP2356218B1 (en) | 2008-12-05 | 2017-05-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method and medium for neural differentiation of pluripotent cells |
US8642334B2 (en) | 2009-02-17 | 2014-02-04 | Memorial Sloan Kettering Cancer Center | Methods of neural conversion of human embryonic stem cells |
WO2010141622A2 (en) | 2009-06-02 | 2010-12-09 | Cornell University | Method to isolate, identify, and use embryonic stem cells directed to forebrain interneuron fate |
US10119120B2 (en) | 2009-08-12 | 2018-11-06 | Kyoto University | Method for inducing differentiation of pluripotent stem cells into neural precursor cells |
AU2010306377B2 (en) * | 2009-10-13 | 2015-01-22 | Stemcell Technologies Canada Inc. | Manipulation of osmolality for differentiating stem cells |
AU2010315166B2 (en) | 2009-11-04 | 2015-01-22 | FUJIFILM Cellular Dynamics, Inc. | Episomal reprogramming with chemicals |
KR101168053B1 (ko) | 2009-11-06 | 2012-07-24 | 연세대학교 산학협력단 | 효율적이고 보편적인 전분화능 줄기세포의 신경세포 분화 유도방법 |
US9097727B2 (en) | 2010-03-03 | 2015-08-04 | Kyoto University | Method for diagnosing a protein misfolding disease using nerve cells derived from iPS cells |
CN102191221B (zh) | 2010-03-17 | 2014-11-19 | 中国人民解放军第二军医大学东方肝胆外科医院 | 一种能无限自我更新的神经干细胞、其制备方法及其用途 |
US20130108669A1 (en) | 2010-04-16 | 2013-05-02 | The Mclean Hospital Corporation | Dopaminergic neurons differentiated from pluripotent stem cells and uses of thereof |
US9453198B2 (en) | 2010-05-25 | 2016-09-27 | Memorial Sloan Kettering Cancer Center | Method of nociceptor differentiation of human embryonic stem cells and uses thereof |
WO2011159726A2 (en) | 2010-06-14 | 2011-12-22 | The Scripps Research Institute | Reprogramming of cells to a new fate |
JP5936134B2 (ja) | 2010-06-15 | 2016-06-15 | 国立大学法人京都大学 | ヒト人工多能性幹細胞の選択方法 |
CN101935635A (zh) * | 2010-07-30 | 2011-01-05 | 中国人民解放军第二军医大学 | 人骨髓多能干细胞的体外扩增和向多巴胺能神经元定向分化的方法 |
WO2012034101A2 (en) | 2010-09-09 | 2012-03-15 | The Regents Of The University Of California | Expandable cell source of neuronal stem cell populations and methods for obtaining and using them |
JP6196213B2 (ja) | 2011-05-20 | 2017-09-13 | ザ マクレーン ホスピタル コーポレーション | ニューロン前駆細胞および使用法 |
KR101331034B1 (ko) | 2011-06-09 | 2013-11-19 | 연세대학교 산학협력단 | 미분화 줄기세포로부터 중뇌특이적 도파민 신경세포의 제조 방법 |
WO2013016662A1 (en) | 2011-07-28 | 2013-01-31 | Memorial Sloan-Kettering Cancer Center | Diagnosis and treatment of parkinson's disease |
US10280398B2 (en) * | 2011-11-04 | 2019-05-07 | Memorial Sloan-Kettering Cancer Center | Midbrain dopamine (DA) neurons for engraftment |
US10472607B2 (en) | 2011-12-14 | 2019-11-12 | National Chung Hsing University | Culture medium and method for inducing differentiation of pluripotent stem cells into neuroepithelial cells |
EP2614829A1 (en) | 2012-01-11 | 2013-07-17 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Mammalian neural plate border stem cells capable of forming neural tube and neural crest cell lineages including central and peripheral neurons |
CN102604894B (zh) | 2012-02-29 | 2014-07-30 | 中国科学院广州生物医药与健康研究院 | 用于制备神经干细胞的培养基及其用途 |
CN104379732B (zh) | 2012-04-24 | 2018-08-17 | 国际干细胞公司 | 由人多能干细胞衍生神经干细胞和多巴胺能神经元 |
JP6143027B2 (ja) | 2012-12-28 | 2017-06-07 | 国立大学法人京都大学 | アストロサイトの誘導方法 |
US10039794B2 (en) | 2013-02-15 | 2018-08-07 | International Stem Cell Corporation | Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases |
US20140248696A1 (en) | 2013-03-01 | 2014-09-04 | Wisconsin Alumni Research Foundation | Methods of maintaining, expanding, and diffrentiating neuronal subtype specific progenitors |
EP2986710A4 (en) | 2013-04-16 | 2016-11-09 | Sloan Kettering Inst Cancer | AGE-MODIFIED CELLS AND METHOD FOR PRODUCING AGED-MODIFIED CELLS |
AU2014256876B2 (en) | 2013-04-26 | 2020-11-12 | Cornell, University | Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells |
EP3042951B1 (en) | 2013-09-05 | 2019-02-20 | Kyoto University | New method for inducing dopamine-producing neural precursor cells |
CN105814192A (zh) | 2013-10-09 | 2016-07-27 | 加利福尼亚大学董事会 | 哺乳动物视网膜干细胞产生方法和应用 |
KR20230008892A (ko) | 2013-11-21 | 2023-01-16 | 메모리얼 슬로안 케터링 캔서 센터 | 인간 다능성 줄기 세포로부터 기능적 두개 기원판 유도체의 전문화 |
US9694036B2 (en) | 2014-03-21 | 2017-07-04 | Cellular Dynamics International, Inc. | Production of midbrain dopaminergic neurons and methods for the use thereof |
WO2015143622A1 (zh) | 2014-03-25 | 2015-10-01 | 云南中科灵长类生物医学重点实验室 | 一种建立神经上皮干细胞的培养基、方法及其应用 |
CA2965248A1 (en) | 2014-10-24 | 2016-04-28 | Sumitomo Dainippon Pharma Co., Ltd. | Production method for nerve tissue |
EP3280426A2 (en) | 2015-04-09 | 2018-02-14 | Biolamina AB | Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases |
-
2012
- 2012-11-02 US US14/356,042 patent/US10280398B2/en active Active
- 2012-11-02 CA CA2854578A patent/CA2854578C/en active Active
- 2012-11-02 KR KR1020227025750A patent/KR102581669B1/ko active IP Right Grant
- 2012-11-02 KR KR1020237031951A patent/KR20230136702A/ko active IP Right Grant
- 2012-11-02 EP EP12846715.6A patent/EP2773748B1/en active Active
- 2012-11-02 KR KR1020207014325A patent/KR102426327B1/ko active IP Right Grant
- 2012-11-02 EP EP19215962.2A patent/EP3693455A1/en active Pending
- 2012-11-02 PL PL12846715T patent/PL2773748T3/pl unknown
- 2012-11-02 ES ES12846715T patent/ES2779453T3/es active Active
- 2012-11-02 EA EA201490796A patent/EA201490796A1/ru unknown
- 2012-11-02 IL IL286793A patent/IL286793B/en unknown
- 2012-11-02 CN CN201910438393.7A patent/CN113528442A/zh active Pending
- 2012-11-02 CN CN201910438392.2A patent/CN110684734A/zh active Pending
- 2012-11-02 JP JP2014541125A patent/JP6461602B2/ja active Active
- 2012-11-02 CA CA3177246A patent/CA3177246A1/en active Pending
- 2012-11-02 WO PCT/US2012/063339 patent/WO2013067362A1/en active Application Filing
- 2012-11-02 CN CN201280066145.0A patent/CN104379731A/zh active Pending
- 2012-11-02 CN CN201910438266.7A patent/CN110684733A/zh active Pending
- 2012-11-02 AU AU2012332269A patent/AU2012332269B2/en active Active
- 2012-11-02 BR BR122020000182A patent/BR122020000182B8/pt active IP Right Grant
- 2012-11-02 BR BR112014010776-9A patent/BR112014010776B1/pt active IP Right Grant
- 2012-11-02 PT PT128467156T patent/PT2773748T/pt unknown
- 2012-11-02 IL IL295556A patent/IL295556A/en unknown
- 2012-11-02 DK DK12846715.6T patent/DK2773748T3/da active
- 2012-11-02 CN CN201910438394.1A patent/CN113481159A/zh active Pending
- 2012-11-02 KR KR1020147014950A patent/KR102115273B1/ko active IP Right Grant
-
2014
- 2014-05-04 IL IL232450A patent/IL232450B/en active IP Right Grant
-
2015
- 2015-03-10 HK HK15102423.6A patent/HK1201879A1/xx unknown
-
2017
- 2017-06-20 JP JP2017120341A patent/JP6588500B2/ja active Active
-
2018
- 2018-08-24 JP JP2018156902A patent/JP6756786B2/ja active Active
- 2018-08-30 AU AU2018222997A patent/AU2018222997B2/en active Active
-
2019
- 2019-03-14 US US16/353,546 patent/US10711243B2/en active Active
-
2020
- 2020-04-12 IL IL273910A patent/IL273910B/en unknown
- 2020-06-03 US US16/892,000 patent/US11970712B2/en active Active
- 2020-06-19 JP JP2020106370A patent/JP7225163B2/ja active Active
- 2020-09-04 JP JP2020149072A patent/JP2021000104A/ja active Pending
-
2021
- 2021-08-19 AU AU2021218116A patent/AU2021218116B2/en active Active
-
2022
- 2022-11-14 JP JP2022181703A patent/JP2023027064A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2773748T3 (da) | Midthjerne-dopamin (da) neuroner til transplantation | |
DK3225604T3 (da) | Fremgangsmåde til fremstilling af flerlagsruder | |
DK3351631T3 (da) | Fremgangsmåder til mærkning af dna-kodede biblioteker | |
DK2906696T3 (da) | Fremgangsmåder til modulering af c9orf72-ekspression | |
DK2708147T3 (da) | Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose | |
DK3702374T3 (da) | Fremsgangsmåde til fremstilling for cyclodextrin-derivater | |
DK2934187T3 (da) | Økonomisk fremgangsmåde til isolering af funktionelt protein fra planter | |
DK3395357T3 (da) | Sammensætning til kontrolleret ovariestimulering | |
EP2794880A4 (en) | METHODS FOR MODULATING EXPRESSION OF METASTASIS-ASSOCIATED ADENOCARCINOMA TRANSCRIPT (MALAT-1) | |
DK3366358T3 (da) | Bæresystem til brandsikringssprinkler | |
DK2849760T3 (da) | Fremgangsmåder til oligonukleotid-chelatkompleks | |
IT1404008B1 (it) | Componente per filtri | |
DK2834229T3 (da) | Fremgangsmåde til fremstilling af ccr3-inhibitorer | |
FI20115336A (fi) | Suihkutuspää | |
DK2916661T3 (da) | Fremgangsmåde til opnåelse af bloom-hæmmende komponenter til konfektureprodukter | |
DK2872536T3 (da) | Fremgangsmåde til ekstraktion af biomasse | |
DK2788353T3 (da) | Bur-aminligander til metallo-radiofarmaceutika | |
DK2809343T3 (da) | Fremgangsmåde til fermentering | |
FI20125806A (fi) | Jonotusmenetelmä | |
BR112014015030A2 (pt) | variantes da endoflucanase 1b (eg1b) | |
DK2522421T3 (da) | Fremgangsmåde til opnåelse af mikrokapsler | |
DK2478758T3 (da) | Fordelermaskine | |
BR112014008223A2 (pt) | heterociclilpiri (mi) dinilpirazol | |
SI2665384T1 (sl) | Samostojna nosljiva zaščitna priprava in sklop zaščitnega oblačila | |
CO6870043A2 (es) | Procedimiento de preparación de compuestos de pirazol n-sustituidos |